Germany
Oncology drug development
Rare disease therapeutics
Diagnostic devices
Point-of-care testing
Pharmaceutical research and development
Biberach an der Riß, Germany
Dr. Hans-Georg Geistlich
Company name
Group
Parent
Subsidiary
Customer
Supplier
Alliance
Bank
Shareholder
DELTA Zofingen AG
Group
Subsidiary
Geistlich Immobilia AG
Group
Loading...
Loading the relationship graph...
2026-09-21 18:17 (Model: ggml-org/gpt-oss-20b )